Effect of steroid and cyclosporine in Membranous Nephropathy that is resistant to steroid and/or cytotoxic treatment

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 1, 2014, Pages 255-261

  Coban, Melahat ^a   Eke, Remziye Nur ^a   Kizilates, Filiz ^b   Ucar, Secil ^c   Dede, Fatih ^d  

^a Antalya Education and Research Hospital ^*  (Turkey)

^b Antalya Education and Research Hospital   (Turkey)

^c Acibadem Fulya Hospital   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cyclosporine; Membranous nephropathy; Steroid

Indexed keywords

EID: 84892619477     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Davison AM, Cameron JS, Kerr DNS, Ogg CS, Wilkinson RW. The natural history of renal function of in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrology 1984; 22: 61-67.
2. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000; 35: 878-83.
3. Hogan SL, Muller KE, Jenette JC, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995; 25: 862-75.
4. Ponticelli C, Glassock RJ. Treatment of primary glomerulonephritis. 2nd edition. 2010; pp: 267.
5. Pei Y, Cattran D, Greenwood C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 1992; 42: 960-966.
6. Bazzi C, Petrini C, Rizza V, Arrigo G. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 2000; 58: 1732-1741
7. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nefropathy. N Eng J Med 1984; 310: 946-50.
8. Hogan S, Muller KE, Jennette JC, Falk RG. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995; 25: 862-875.
9. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C. A 10-years follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-1604.
10. Ponticelli C, Altieri P, Scolari F, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclosphosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998; 9: 444-450.
11. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S. A randomized controlled trial of prednisone in patients with idiopathic membranous neprhopathy. N Engl J Med 1989; 320: 210-215.
12. Cameron JS, Healy MJ, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolene in idiopathic membranous nephropathy with nephrotic syndrome in adults: the MRC Glomerulonephritis Working Party. QJM 1990; 74: 133-156.
13. Kincaid-Smith P. Pharmacological management of membranous nephropathy. Curr Opin Nephrol Hypertens 2002; 11: 149-54.
14. Ponticelli C, Passerini P. Treatment of membranous nephropathy. Nephrol Dial Transplant 2001; 16: 8-10.
15. Ponticelli C, Zucchelli P, Passerini P. A 10-year follow up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-4.
16. Cattran DC, Appel GB, Hebert LA. Cyclosporine in patients with steroid-resistent membranous nephropathy: a randomized trial. Kidney Int 1995; 59: 1484-1490.
17. Ehrenreich T and Churg J. Pathology of membranous nephropathy. In: Sommers SC, eds. Pathology Annual. New York: Appleton-Century-Crofts; 1986. pp: 145-146.
18. Ponticelli C and Villa M. Does cyclosporine have a role in the treatment of membranous nephropathy? Nephrol Dial Transplant 1999; 14: 23-25.
19. Alexopoulos E, Papagianni A, Tsamelashvielli M, Leontsini M, Memmos D. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006; 21: 3127-32.
20. Rostoker G, Belghiti D, Maadi AB. Long-term cyclosporine A therapy for severe idiopathic membranous nephropathy. Nephron 1993; 63: 335-341.
21. Guasch A, Suraniy M, Newton L, Hall BM, Myers BD, Short-term responsiveness of membranous glomerulonephropathy to cyclosporine. Am J Kidney Dis 1992; 20: 472-481.
22. Meyrier A, Antiproteinuric and immunological effects of cyclosporine A in the treatment of glomerular diseases. Nephrol Dial Transplant 1992; 7: 80-84.
23. Fritsche L, Budde K, Farber L, Charisse G, Kunz R, Gaedeke J, Neumayer HH. Treatment of membranous glomerulopathy with cyclosporine A: how much patience is reguired? Nephrol Dial Transplant 1999; 14: 1036-8.
24. Laluck BJ, Cattran DC. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis 1999; 33: 1026-32.
25. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-65.
26. Neugarten J, Acharya A, Silbiger SR. Effects of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11: 319-29.
27. Feutren G, Mihatsch MJ. Risk factor for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-1660.
28. Meyrier A, Noel H, Auriche P, Callard P and the Collaborative Group of the Societe de Nephrologie: Long-term renal tolerance of cyclosporine A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994; 45: 1446-1456.